For FY13, the Integrated Research Facility in the Division of Clinical Research has significantly increased the level of research facilitation that it provides. Primarily, this support has been directed to facilitating the biodefense and emerging infectious disease research of the Emerging Viral Pathogens section in the Division of Intramural Research, reported separately. In addition, core capabilities of the IRF have been established to include clinical pathology, anatomic pathology, electron microscopy, confocal microscopy, immunology, and cell culture. Rodents were introduced into the facility in Nov 2012 followed by primates in December of the same year. Medical imaging using all four modalities on uninfected animals was initiated in January 2013 followed by infections non-Select Agents in March and aerosol infectivity studies in April, plus influenza and MERS in July.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2013
Total Cost
$19,981,023
Indirect Cost
City
State
Country
Zip Code
Johnson, Reed F; Bagci, Ulas; Keith, Lauren et al. (2016) 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012. Virology 490:49-58
Johnson, Reed F; Hammoud, Dima A; Perry, Donna L et al. (2016) Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease. J Gen Virol 97:1942-54
Luke, Thomas; Wu, Hua; Zhao, Jincun et al. (2016) Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med 8:326ra21
Wahl-Jensen, Victoria; Johnson, Joshua C; Lauck, Michael et al. (2016) Divergent Simian Arteriviruses Cause Simian Hemorrhagic Fever of Differing Severities in Macaques. MBio 7:e02009-15
Broce, Sean; Hensley, Lisa; Sato, Tomoharu et al. (2016) Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals. Biol Direct 11:25
Johnson, Reed F; Kurup, Drishya; Hagen, Katie R et al. (2016) An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models. J Infect Dis 214:S342-S354
Olsen, Michelle E; Filone, Claire Marie; Rozelle, Dan et al. (2016) Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication. MBio 7:
Yú, Shu Qìng; Caì, Yíngyún; Lyons, Cassandra et al. (2016) Specific Detection of Two Divergent Simian Arteriviruses Using RNAscope In Situ Hybridization. PLoS One 11:e0151313
Ewers, Evan C; Pratt, William D; Twenhafel, Nancy A et al. (2016) Natural History of Aerosol Exposure with Marburg Virus in Rhesus Macaques. Viruses 8:87
Bohannon, J Kyle; Lackemeyer, Matthew G; Kuhn, Jens H et al. (2015) Generation and characterization of large-particle aerosols using a center flow tangential aerosol generator with a non-human-primate, head-only aerosol chamber. Inhal Toxicol 27:247-53

Showing the most recent 10 out of 46 publications